Gabon is taking steps to safeguard iboga, a plant integral to its cultural traditions, as pharmaceutical companies show increasing interest in its potential for treating addiction and mental health issues. An executive order in the U.S. has highlighted ibogaine, a compound derived from iboga, prompting concerns over ecological sustainability and the preservation of traditional knowledge associated with the plant.
The Gabonese government has enacted measures to ensure benefit-sharing from commercial use of iboga, recognizing its cultural significance. This includes a decree that mandates the disclosure of the plant's origin in patent applications and establishes a sovereign fund to support local communities, aiming to prevent exploitation as the global market for ibogaine develops.